TY - JOUR
T1 - Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas
AU - Hendel, Helle W
AU - Daugaard, Soeren
AU - Kjaer, Andreas
PY - 2002/9
Y1 - 2002/9
N2 - PURPOSE: The current study was designed to evaluate the role of planar bone scintigraphy in the diagnosis of sarcomatous change in osteochondromas (cartilaginous exostoses).MATERIALS AND METHODS: Histologically verified cases of chondrosarcoma and osteochondroma, in which Tc-99m bone scintigraphy was performed, were reviewed in a retrospective study.RESULTS: Twenty-two cases were evaluated. Of 11 cases with chondrosarcomas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. Of the 11 cases with osteochondromas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. No significant difference in the distribution of scintigraphic results was noted between the two pathoanatomic groups (p = 1).CONCLUSION: In conclusion, single standing planar bone scintigraphy has no value in distinguishing benign osteochondromas from malignant chondrosarcomas.
AB - PURPOSE: The current study was designed to evaluate the role of planar bone scintigraphy in the diagnosis of sarcomatous change in osteochondromas (cartilaginous exostoses).MATERIALS AND METHODS: Histologically verified cases of chondrosarcoma and osteochondroma, in which Tc-99m bone scintigraphy was performed, were reviewed in a retrospective study.RESULTS: Twenty-two cases were evaluated. Of 11 cases with chondrosarcomas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. Of the 11 cases with osteochondromas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. No significant difference in the distribution of scintigraphic results was noted between the two pathoanatomic groups (p = 1).CONCLUSION: In conclusion, single standing planar bone scintigraphy has no value in distinguishing benign osteochondromas from malignant chondrosarcomas.
KW - Adult
KW - Bone Neoplasms/diagnostic imaging
KW - Chondrosarcoma/diagnostic imaging
KW - Databases, Factual
KW - Diagnosis, Differential
KW - Humans
KW - Middle Aged
KW - Osteochondroma/diagnostic imaging
KW - Predictive Value of Tests
KW - Radionuclide Imaging
KW - Retrospective Studies
KW - Technetium/pharmacokinetics
KW - Tissue Distribution
U2 - 10.1097/01.RLU.0000023879.58875.B1
DO - 10.1097/01.RLU.0000023879.58875.B1
M3 - Journal article
C2 - 12192277
VL - 27
SP - 622
EP - 624
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
SN - 0363-9762
IS - 9
ER -